Lung cancer Natural History, Complications and Prognosis
|
Lung cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lung cancer Natural History, Complications and Prognosis On the Web |
|
American Roentgen Ray Society Images of Lung cancer Natural History, Complications and Prognosis |
|
FDA on Lung cancer Natural History, Complications and Prognosis |
|
CDC on Lung cancer Natural History, Complications and Prognosis |
|
Lung cancer Natural History, Complications and Prognosis in the news |
|
Blogs on Lung cancer Natural History, Complications and Prognosis |
|
Risk calculators and risk factors for Lung cancer Natural History, Complications and Prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, Saarah T. Alkhairy M.D, Dildar Hussain, MBBS [2]
Overview
The majority of lung cancers present with advanced disease because the symptoms tend to occur later in the course of the disease. Patients experience non-specific symptoms such as cough, hemoptysis, dyspnea, chest pain, difficulty speaking, difficulty swallowing, lack of appetite, weight loss, and fatigue from 3 weeks to 3 months before seeking medical attention. There are a variety of complications associated with lung cancer, such as pleural effusion, leg weakness, paresthesias, bladder dysfunction, seizures, hemiplegia, cranial nerve palsies, confusion, personality changes, skeletal pain, pleuritic pain, atelectasis, and bronchopleural fistula. The prognosis of lung cancer is poor if diagnosed at the advanced stages.
Natural History, Complications, and Prognosis
Natural History
- The majority of lung cancers present with advanced disease because the symptoms tend to occur later in the course of the disease.[1]
- Patients experience non-specific symptoms such as cough, hemoptysis, dyspnea, chest pain, difficulty speaking, difficulty swallowing, lack of appetite, weight loss, and fatigue from 3 weeks to 3 months before seeking medical attention.
- Depending on the duration of the presence of symptoms, the tumor cells may double 20 times.[1]
- In more advanced disease, the tumor may spread to other organs such as the spinal cord, brain, and bone.
- These patients may develop symptoms such as leg weakness, paresthesias, bladder dysfunction, seizures, hemiplegia, cranial nerve palsies, confusion, personality changes, skeletal pain, and pleuritic pain.[1]
- Once the cancer spreads to the other organs, it is most likely fatal.
Complications
General Complications
The complications associated with lung cancer are:[2][3]
- If the cancer grows in the airway, it may obstruct airflow, causing breathing difficulties. This can lead to accumulation of secretions behind the blockage, predisposing the patient to pneumonia.
- Occasionally, lung cancer can cause bleeding in the airways which can result in hemoptysis.
- In many cases, lung cancer will spread to other parts of the body. Some of the more common places lung cancer metastasizes to are the bones, liver, brain, and adrenal glands.
- Tumors in the apex of the lung, known as Pancoast tumors, may invade locally into the sympathetic nervous system leading to Horner's syndrome.
- Superior vena cava syndrome
- SVCS is a group of symptoms caused by obstruction of the superior vena cava. More than 60% of cases of superior vena cava obstruction are caused by malignancies, especially with a tumor outside the vessel compressing the vessel wall.
Surgical Complications
- It is when air leaks from a pneumonectomy bronchial stump.
- Approximately 2% of the patients that undergo a pneumonectomy experience this.
- It will most commonly occur approximately 7 to 10 days after surgery.
- Atelectasis
- Sputum retention
Prognosis
The prognosis of lung cancer is poor and it depends on the following factors:
- Whether or not the tumor can be removed by surgery
- Stage of the cancer
- Patient’s general health
- Whether the cancer has just been diagnosed or has recurred
Non-small Cell Lung Cancer Survival Rate by Stage[4]
| Stage | 5-year survival rate |
|---|---|
| IA | 49% |
| IB | 45% |
| IIA | 30% |
| IIB | 31% |
| IIIA | 14% |
| IIIB | 5% |
| IV | 1% |
Small Cell Lung Cancer Survival Rate
References
- ↑ 1.0 1.1 1.2 Leary, A (2012). Lung cancer a multidisciplinary approach. Chichester, West Sussex, UK Ames, Iowa: Wiley-Blackwell. ISBN 9781405180757.
- ↑ Jones, DR (Jul 1998). "Pancoast tumors of the lung". Current Opinion in Pulmonary Medicine. 4 (4): 191–197. PMID 10813231. Unknown parameter
|coauthors=ignored (help) - ↑ Eren S, Karaman A, Okur A (2006). "The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT". Eur J Radiol. 59 (1): 93–103. doi:10.1016/j.ejrad.2006.01.003. PMID 16476534.
- ↑ Lung cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/prognosis-and-survival/survival-statistics/?region=ab